Commentary: Does Severity of Alzheimer's Disease Contribute to Its Responsiveness to Modifying Gut Microbiota? A Double Blind Clinical Trial

Detalles Bibliográficos
Autores principales: Leblhuber, Friedrich, Steiner, Kostja, Schuetz, Burkhard, Fuchs, Dietmar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6624731/
https://www.ncbi.nlm.nih.gov/pubmed/31333558
http://dx.doi.org/10.3389/fneur.2019.00667
_version_ 1783434277749260288
author Leblhuber, Friedrich
Steiner, Kostja
Schuetz, Burkhard
Fuchs, Dietmar
author_facet Leblhuber, Friedrich
Steiner, Kostja
Schuetz, Burkhard
Fuchs, Dietmar
author_sort Leblhuber, Friedrich
collection PubMed
description
format Online
Article
Text
id pubmed-6624731
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-66247312019-07-22 Commentary: Does Severity of Alzheimer's Disease Contribute to Its Responsiveness to Modifying Gut Microbiota? A Double Blind Clinical Trial Leblhuber, Friedrich Steiner, Kostja Schuetz, Burkhard Fuchs, Dietmar Front Neurol Neurology Frontiers Media S.A. 2019-07-05 /pmc/articles/PMC6624731/ /pubmed/31333558 http://dx.doi.org/10.3389/fneur.2019.00667 Text en Copyright © 2019 Leblhuber, Steiner, Schuetz and Fuchs. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Leblhuber, Friedrich
Steiner, Kostja
Schuetz, Burkhard
Fuchs, Dietmar
Commentary: Does Severity of Alzheimer's Disease Contribute to Its Responsiveness to Modifying Gut Microbiota? A Double Blind Clinical Trial
title Commentary: Does Severity of Alzheimer's Disease Contribute to Its Responsiveness to Modifying Gut Microbiota? A Double Blind Clinical Trial
title_full Commentary: Does Severity of Alzheimer's Disease Contribute to Its Responsiveness to Modifying Gut Microbiota? A Double Blind Clinical Trial
title_fullStr Commentary: Does Severity of Alzheimer's Disease Contribute to Its Responsiveness to Modifying Gut Microbiota? A Double Blind Clinical Trial
title_full_unstemmed Commentary: Does Severity of Alzheimer's Disease Contribute to Its Responsiveness to Modifying Gut Microbiota? A Double Blind Clinical Trial
title_short Commentary: Does Severity of Alzheimer's Disease Contribute to Its Responsiveness to Modifying Gut Microbiota? A Double Blind Clinical Trial
title_sort commentary: does severity of alzheimer's disease contribute to its responsiveness to modifying gut microbiota? a double blind clinical trial
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6624731/
https://www.ncbi.nlm.nih.gov/pubmed/31333558
http://dx.doi.org/10.3389/fneur.2019.00667
work_keys_str_mv AT leblhuberfriedrich commentarydoesseverityofalzheimersdiseasecontributetoitsresponsivenesstomodifyinggutmicrobiotaadoubleblindclinicaltrial
AT steinerkostja commentarydoesseverityofalzheimersdiseasecontributetoitsresponsivenesstomodifyinggutmicrobiotaadoubleblindclinicaltrial
AT schuetzburkhard commentarydoesseverityofalzheimersdiseasecontributetoitsresponsivenesstomodifyinggutmicrobiotaadoubleblindclinicaltrial
AT fuchsdietmar commentarydoesseverityofalzheimersdiseasecontributetoitsresponsivenesstomodifyinggutmicrobiotaadoubleblindclinicaltrial

Ejemplares similares